Veracyte Sustainability Profile
Veracyte, Inc., a leading genomic diagnostics company headquartered in the United States, is at the forefront of transforming patient care through innovative solutions. Founded in 2013, Veracyte has made significant strides in the field of molecular diagnostics, particularly in oncology and pulmonary diseases. The company’s core offerings include advanced genomic tests that provide critical insights for accurate disease diagnosis and management, setting them apart in a competitive market. With a strong presence in the US and expanding operations globally, Veracyte has established itself as a trusted partner for healthcare providers. Notable achievements include the development of unique tests that enhance the diagnostic process, thereby improving patient outcomes. As a pioneer in the industry, Veracyte continues to lead the way in precision medicine, making significant contributions to the evolving landscape of genomic healthcare.
DitchCarbon Score
How does Veracyte's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Veracyte's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Veracyte's reported carbon emissions
Veracyte, Inc., headquartered in the United States, currently does not report any specific carbon emissions data for the latest year. As of May 2024, the company has committed to near-term climate targets, although no specific reduction targets or net-zero commitments have been established. Veracyte operates within the Healthcare Providers and Services sector, and its climate initiatives are aligned with industry standards. The company is actively engaged in climate commitments, as indicated by its status of being "Committed" to near-term targets. However, details regarding the scope of emissions (Scope 1, 2, or 3) and specific reduction goals remain unspecified. Veracyte's climate strategy appears to be in the early stages, with no inherited emissions data from a parent company or corporate family relationship. In summary, while Veracyte has made strides in committing to climate action, specific emissions data and reduction targets are currently unavailable, highlighting an opportunity for further transparency and progress in their sustainability efforts.
How Carbon Intensive is Veracyte's Industry?
How Carbon Intensive is Veracyte's Location?
Veracyte's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Veracyte has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
